SpectraCure AB (2OK) Stock Statistics & Valuation Metrics

SpectraCure AB has a market cap or net worth of €9.08M. The enterprise value is €18.05M.

SpectraCure AB has 401,334,320 shares outstanding. The number of shares has decreased by -2.65% in one year.

SpectraCure AB’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -21.87%.

The current PE Ratio of SpectraCure AB is ―. SpectraCure AB’s PEG ratio is ―.

In the last 12 months, SpectraCure AB had revenue of 0.00 and earned -23.00M in profits. Earnings per share was -0.24.

In the last 12 months, operating cash flow was -11.51M and capital expenditures -15.98M, giving a free cash flow of -27.49M billion.

SpectraCure AB pays an annual dividend of ―, resulting in a dividend yield of ―

SpectraCure AB upcoming earnings date is Aug 21, 2025, Before Open (Confirmed).

SpectraCure AB as a current ratio of 1.93, with Debt / Equity ratio of 2.96%

In the past 12 months, SpectraCure AB has paid 7.00K in taxes.

SpectraCure AB EV to EBITDA ratio is -11.49, with an EV/FCF ratio of -6.32.

SpectraCure AB has €9.25M in cash and marketable securities with €3.99M in debt, giving a net cash position of €5.26M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for SpectraCure AB is €0.04, which is 11.43% higher than the current price. The consensus rating is Moderate Sell